Download in electronic PDF format for $25

Kalchem International - Chemicals and Compounding Supplies

Search the Complete Journal Archives

Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications

Author(s):  Zur Eyal

Issue:  Nov/Dec 2018 - Volume 22, Number 6
View All Articles in Issue

Abstract:  Radiotherapy and epidermal growth factor receptor inhibitors, as important representatives of current chemotherapy, are crucial and irreplaceable treatments of modern oncology. These two types of treatments frequently cause severe dose-dependent dermatologic adverse events that can negatively affect a patient’s quality of life and compliance and cause inappropriate dose reductions and even treatment brakes. This article aims to emphasize new scientific data, published in peer reviews, regarding new possibilities to manage these debilitating dermatological adverse events. Since part of the scientific findings is new, the responsibility to enable pharmacologic treatment is in the compounding pharmacist domain. The article also suggests new formulations to the new pharmacologic treatment.

Related Keywords: Eyal Zur, BSc Pharm, RPh, MBA, cancer medicine, medical oncology, radiotherapy, epidermal growth factor receptor inhibitors, EGFR, dermatologic adverse events, acneiform rash, paronychia, inflammation, mucositis, xerosis, pruritus, hair changes, inflammatory changes, fingernails, keratinocytes, formulation, heparinoid cream, heparinoid lotion, topical preparations, ivermectin cream, ivermectin lotion, 5-aminolevulinic acid hydrochloride cream, case reports, radiation dermatitis, propranolol hydrochloride, topical corticosteroids

Related Categories: CANCER AND AIDS, DERMATOLOGY, FORMULATIONS, CASE REPORTS, ADVERSE DRUG EVENTS, PREVENTIVE MEDICINE/WELLNESS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Zur Eyal Nov/Dec 2018 446-454 Buy
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Zur Eyal Mar/Apr 2012 117-124 Buy
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Zur Eyal Jan/Feb 2012 22-33 Buy
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K Jan/Feb 2013 74-85 View Sample
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr Nov/Dec 2016 510 Buy
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso Jul/Aug 2014 278-286 Buy
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Zur Eyal Jan/Feb 2014 14-19 Buy
Surviving Cancer - How the Compounding Pharmacist Can Help Maddox Suzan Jul/Aug 2000 257 Buy
Complementary Medicine - A Wellness Plan for People with Diabetes Singer Debra Mar/Apr 2000 101 Buy
Burning Mouth Syndrome: A Discussion of a Complex Pathology Zur Eyal May/Jun 2012 196-205 Buy